SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Cognetix
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Cognetix
Salt Lake City, UT
